Validation of a guideline-based composite outcome assessment tool for asthma control

Por Bendall Kate L, Mayer Bhabita, Spencer Sally, Bateman Eric D
Publicado em 2007-03-01

Validation of a guideline-based composite outcome assessment tool for asthma control

Por Spencer, Sally, Mayer, Bhabita, Bendall, Kate L, Bateman, Eric D
Publicado em 2007

Comment on: “Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists”

Por Samuelsen, Carl, Bateman, Eric D., Pavord, Ian, Lloyd, Adam, Baldwin, Mike, Esser, Dirk
Publicado no Appl Health Econ Health Policy (2015)

Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom

Por Samyshkin, Yevgeniy, Kotchie, Robert W., Mörk, Ann-Christin, Briggs, Andrew H., Bateman, Eric D.
Publicado em 2013

QVA149 Improves Lung Function, Dyspnea, and Health Status Independent of Previously Prescribed Medications and COPD Severity: A Subgroup Analysis from the SHINE and ILLUMINATE Stud...

Por Chapman, Kenneth R., Bateman, Eric D., Chen, Hungta, Hu, Hulin, Fogel, Robert, Banerji, Donald
Publicado no Chronic Obstr Pulm Dis (2015)

Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study

Por Bateman, Eric D., Ferguson, Gary T., Barnes, Neil, Gallagher, Nicola, Green, Yulia, Henley, Michelle, Banerji, Donald
Publicado em 2013

Global asthma prevalence in adults: findings from the cross-sectional world health survey

Por To Teresa, Stanojevic Sanja, Moores Ginette, Gershon Andrea S, Bateman Eric D, Cruz Alvaro A, Boulet Louis-Philippe
Publicado em 2012-03-01

Global asthma prevalence in adults: findings from the cross-sectional world health survey

Por To, Teresa, Stanojevic, Sanja, Moores, Ginette, Gershon, Andrea S, Bateman, Eric D, Cruz, Alvaro A, Boulet, Louis-Philippe
Publicado em 2012

Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study

Por Woodcock, Ashley, Lötvall, Jan, Busse, William W, Bateman, Eric D, Stone, Sally, Ellsworth, Anna, Jacques, Loretta
Publicado em 2014

Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (A...

Por Bateman, Eric D., Chapman, Kenneth R., Singh, Dave, D’Urzo, Anthony D., Molins, Eduard, Leselbaum, Anne, Gil, Esther Garcia
Publicado no Respir Res (2015)

Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment

Por Jenkins, Christine R., Eriksson, Göran, Bateman, Eric D., Reddel, Helen K., Sears, Malcolm R., Lindberg, Magnus, O’Byrne, Paul M.
Publicado no BMC Pulm Med (2017)

Implementing nurse-initiated and managed antiretroviral treatment (NIMART) in South Africa: a qualitative process evaluation of the STRETCH trial

Por Georgeu, Daniella, Colvin, Christopher J, Lewin, Simon, Fairall, Lara, Bachmann, Max O, Uebel, Kerry, Zwarenstein, Merrick, Draper, Beverly, Bateman, Eric D
Publicado em 2012

Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multi...

Por Singh, Dave, Jones, Paul W, Bateman, Eric D, Korn, Stephanie, Serra, Cristina, Molins, Eduard, Caracta, Cynthia, Gil, Esther Garcia, Leselbaum, Anne
Publicado no BMC Pulm Med (2014)

Cigarette smoke impairs cytokine responses and BCG containment in alveolar macrophages

Por van Zyl-Smit, Richard N, Binder, Anke, Meldau, Richard, Semple, Patricia L, Evans, Alicia, Smith, Peter, Bateman, Eric D, Dheda, Keertan
Publicado no Thorax (2013)

Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma

Por Woodcock Ashley, Bleecker Eugene R, Busse William W, Lötvall Jan, Snowise Neil G, Frith Lucy, Jacques Loretta, Haumann Brett, Bateman Eric D
Publicado em 2011-12-01

Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial

Por Woodcock, Ashley, Bateman, Eric D, Busse, William W, Lötvall, Jan, Snowise, Neil G, Forth, Richard, Jacques, Loretta, Haumann, Brett, Bleecker, Eugene R
Publicado em 2011

Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma

Por Woodcock, Ashley, Bleecker, Eugene R, Busse, William W, Lötvall, Jan, Snowise, Neil G, Frith, Lucy, Jacques, Loretta, Haumann, Brett, Bateman, Eric D
Publicado em 2011

Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma: A Randomi...

Por Woodcock, Ashley, Bleecker, Eugene R., Lötvall, Jan, O’Byrne, Paul M., Bateman, Eric D., Medley, Hilary, Ellsworth, Anna, Jacques, Loretta, Busse, William W.
Publicado em 2013

Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma

Por O’Byrne, Paul M., Bleecker, Eugene R., Bateman, Eric D., Busse, William W., Woodcock, Ashley, Forth, Richard, Toler, William T., Jacques, Loretta, Lötvall, Jan
Publicado em 2014

Comparison of vilanterol, a novel long-acting beta(2) agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids

Por Lötvall, Jan, Bateman, Eric D, Busse, William W, O’Byrne, Paul M, Woodcock, Ashley, Toler, William T, Jacques, Loretta, Goldfrad, Caroline, Bleecker, Eugene R
Publicado em 2014